Publication Beamlines Strategic Pillar
(2018). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL263320A.
(2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2.
(2017). ANTI-BCMA ANTIBODIES (CELL MATURATION ANTIGEN B), BINDING SPECIFIC MOLECULES THAT JOIN BCMA AND CD3 (AGGREGATE DETERMINANT 3), AND USES OF THESE. Patent Number: AR105724A1.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2015). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL238684A0.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL320478A.
(2022). ANTIBODY EPITOPE. Patent Number: PT3311171T.
(2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T.
(2015). ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE. Patent Number: AR093446A1.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL298041B2.
(2015). Novel TNFa structure for use in therapy. Patent Number: GB201510758D0.
마르욜레인 키케르트; 브라이언 레너드 마크; 퓍 베르튄 카스테렌 반; ? 베르튄 카스테렌 반; 테렌스 윌리엄 제임스 et al. (2015). Arterivirus. Patent Number: KR20150060744A.
코단다람 필라리세티; 에릭 토마스 볼드윈; 고든 디. 파워스; 로사 마리아 페르난데스 카르도소; 리카도 아타르 et al. (2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: KR20250007058A.
코단다람 필라리세티; 에릭 토마스 볼드윈; 고든 디. 파워스; 로사 마리아 페르난데스 카르도소; 리카도 아타르 et al. (2025). Anti-BCMA antibodies, which are bispecific antigen-binding molecules that bind to BCMA and CD3, and uses thereof. Patent Number: KR102890745B1.